Bengaluru sees rising popularity of anti-obesity injectables

Weight loss injectables like Ozempic are becoming popular in Bengaluru, even though they are not officially available in India. Patients are sourcing these drugs from abroad, and doctors are monitoring their progress. Bariatric surgery referrals have decreased as a result. Eli Lilly plans to launch Mounjaro, a new weight loss drug, in India this year. Mounjaro has shown significant weight loss results and may change obesity treatment in the country. It works differently than Ozempic, targeting appetite control. The demand for bariatric surgery is declining as more people consider injectable drugs. While these medications can aid weight loss, doctors caution that they may not provide long-term results like surgery. Side effects and the risk of weight regain after stopping the drugs are also concerns.